Device Trial Radar · NCT02712398
A Prospective Trial of a Bio-absorbable Mesh in Challenging Laparoscopic Ventral or Incisional Hernia Repair
Last checked: Nov 19, 2026Latest source record: Jan 8, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
120
Actual
Start
Apr 2016
Primary completion
Nov 15, 2019
Study completion Nov 15, 2019
Sponsor
- Lead sponsor
- C. R. BardPublic (BDX)
- Sponsor type
- Industry
- First posted
- Mar 18, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to collect additional data on safety, performance and effectiveness of Phasix™ ST in subjects receiving laparoscopic ventral or incisional hernia repair at high risk for surgical site occurrence (SSO).
Conditions
- Hernia, Ventral
- Incisional Hernia
Interventions
Phasix™ STDevice
Phasix™ ST is a fully resorbable mesh with a hydrogel coating that is also resorbable.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Surgical Site Occurrence RateTime frame: 45 Days
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
Yale-New Haven Medical Center
New Haven, Connecticut
Florida Hospital
Celebration, Florida
Emory University
Atlanta, Georgia
13 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.